Pub Date : 2026-08-10DOI: 10.1007/s10522-026-10487-0
Laura Collopy, Yana Kolenichenko
Telomere length (TL) is a well-established biomarker of biological ageing, sensitive to cumulative physiological and psychosocial stress. This review synthesises current evidence on how pregnancy, postpartum stressors, and reproductive history shape maternal biological ageing, integrating findings from telomere biology and emerging epigenetic ageing measures. Pregnancy represents a period of substantial metabolic, hormonal, and immunological demand and is increasingly conceptualised as a transient state of accelerated biological ageing. While telomere shortening is not consistently detectable during gestation, epigenetic clocks indicate a temporary increase in biological age, which is only partially reversible postpartum. Across the life course, higher parity is associated with shorter TL, with evidence suggesting a cumulative effect that becomes most apparent in later life and around the menopausal transition. However, this relationship is heterogeneous and modified by factors including age at last birth, breastfeeding, and socioeconomic context. Postpartum represents a critical and underexplored window in which sleep deprivation, psychological stress, and social factors converge to influence telomere dynamics. In particular, poor sleep quality and postpartum depression (PPD) are consistently linked to accelerated telomere attrition and epigenetic ageing, with emerging evidence of a bidirectional relationships whereby shorter TL may also predispose to PPD. Overall, evidence supports a model in which reproductive events impose are associated with measurable transient and cumulative costs to cellular ageing biomarkers. These findings highlight the importance of incorporating postpartum health, particularly sleep and mental health support, into life-course models of ageing and underscore the need for longitudinal, mechanistic, and intervention-focused research in maternal populations.
{"title":"Maternal biological ageing and telomere attrition across parity, pregnancy, and the postpartum period.","authors":"Laura Collopy, Yana Kolenichenko","doi":"10.1007/s10522-026-10487-0","DOIUrl":"10.1007/s10522-026-10487-0","url":null,"abstract":"<p><p>Telomere length (TL) is a well-established biomarker of biological ageing, sensitive to cumulative physiological and psychosocial stress. This review synthesises current evidence on how pregnancy, postpartum stressors, and reproductive history shape maternal biological ageing, integrating findings from telomere biology and emerging epigenetic ageing measures. Pregnancy represents a period of substantial metabolic, hormonal, and immunological demand and is increasingly conceptualised as a transient state of accelerated biological ageing. While telomere shortening is not consistently detectable during gestation, epigenetic clocks indicate a temporary increase in biological age, which is only partially reversible postpartum. Across the life course, higher parity is associated with shorter TL, with evidence suggesting a cumulative effect that becomes most apparent in later life and around the menopausal transition. However, this relationship is heterogeneous and modified by factors including age at last birth, breastfeeding, and socioeconomic context. Postpartum represents a critical and underexplored window in which sleep deprivation, psychological stress, and social factors converge to influence telomere dynamics. In particular, poor sleep quality and postpartum depression (PPD) are consistently linked to accelerated telomere attrition and epigenetic ageing, with emerging evidence of a bidirectional relationships whereby shorter TL may also predispose to PPD. Overall, evidence supports a model in which reproductive events impose are associated with measurable transient and cumulative costs to cellular ageing biomarkers. These findings highlight the importance of incorporating postpartum health, particularly sleep and mental health support, into life-course models of ageing and underscore the need for longitudinal, mechanistic, and intervention-focused research in maternal populations.</p>","PeriodicalId":8909,"journal":{"name":"Biogerontology","volume":"27 4","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13457282/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148700787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-08-07DOI: 10.1007/s10522-026-10480-7
Esraa M Mosalam, Mahmoud S Abdallah, Ahmed R Gardouh, Eman Hamza, Mostafa M Bahaa, Mahmoud Nazih, Reham A Al-Dhelaan, Noha Kamal
Aging is a multifactorial process affects different tissues and organs and is modulated by genetic and environmental factors. In aging, the frequency of DNA repair errors and genomic instability are augmented. Depletion of endogenous antioxidant capacity during aging promotes the development of oxidative stress which triggers oxidative stress-induced DNA injury. Brain aging is manifested by cognitive impairment and memory disorders. Development of neuronal senescence is the major pathway in the progression of brain aging. Silent information regulator sirtuin 1 (SIRT1) is a class III histone deacetylase plays a critical role in genomic stability during aging. SIRT1 is highly expressed in specific brain regions involved in energy expenditure and metabolic activity that is necessary for brain development and control of brain senescence. Therefore, SIRT1 may have neuroprotective effects against brain aging and related neurodegenerative diseases. This narrative review aims to critically evaluate the role of SIRT1 in brain aging and to summarize current evidence on compounds that directly or indirectly modulate SIRT1 activity, with a focus on their mechanistic pathways and potential therapeutic implications. Findings of the present review highlighted that SIRT1 activators such as resveratrol, metformin and statins have neuroprotective effects against brain aging by regulating inflammatory and oxidative stress disorders through modulation of downstream signaling pathways.
衰老是一个影响不同组织和器官的多因素过程,受遗传和环境因素的调节。在衰老过程中,DNA修复错误和基因组不稳定性的频率增加。衰老过程中内源性抗氧化能力的消耗促进氧化应激的发展,从而引发氧化应激诱导的DNA损伤。大脑老化表现为认知障碍和记忆障碍。神经元衰老的发生是脑衰老的主要途径。沉默信息调节因子SIRT1 (Silent information regulator SIRT1)是一种III类组蛋白去乙酰化酶,在衰老过程中对基因组稳定性起关键作用。SIRT1在参与能量消耗和代谢活动的特定大脑区域高度表达,这是大脑发育和控制大脑衰老所必需的。因此,SIRT1可能对脑老化及相关神经退行性疾病具有神经保护作用。本文旨在批判性地评估SIRT1在脑衰老中的作用,并总结目前关于直接或间接调节SIRT1活性的化合物的证据,重点是它们的机制途径和潜在的治疗意义。本综述的研究结果强调SIRT1激活剂如白藜芦醇、二甲双胍和他汀类药物通过调节下游信号通路调节炎症和氧化应激障碍,具有抗脑衰老的神经保护作用。
{"title":"SIRT1 in brain aging: molecular mechanisms and therapeutic potential of pharmacological and natural modulators.","authors":"Esraa M Mosalam, Mahmoud S Abdallah, Ahmed R Gardouh, Eman Hamza, Mostafa M Bahaa, Mahmoud Nazih, Reham A Al-Dhelaan, Noha Kamal","doi":"10.1007/s10522-026-10480-7","DOIUrl":"https://doi.org/10.1007/s10522-026-10480-7","url":null,"abstract":"<p><p>Aging is a multifactorial process affects different tissues and organs and is modulated by genetic and environmental factors. In aging, the frequency of DNA repair errors and genomic instability are augmented. Depletion of endogenous antioxidant capacity during aging promotes the development of oxidative stress which triggers oxidative stress-induced DNA injury. Brain aging is manifested by cognitive impairment and memory disorders. Development of neuronal senescence is the major pathway in the progression of brain aging. Silent information regulator sirtuin 1 (SIRT1) is a class III histone deacetylase plays a critical role in genomic stability during aging. SIRT1 is highly expressed in specific brain regions involved in energy expenditure and metabolic activity that is necessary for brain development and control of brain senescence. Therefore, SIRT1 may have neuroprotective effects against brain aging and related neurodegenerative diseases. This narrative review aims to critically evaluate the role of SIRT1 in brain aging and to summarize current evidence on compounds that directly or indirectly modulate SIRT1 activity, with a focus on their mechanistic pathways and potential therapeutic implications. Findings of the present review highlighted that SIRT1 activators such as resveratrol, metformin and statins have neuroprotective effects against brain aging by regulating inflammatory and oxidative stress disorders through modulation of downstream signaling pathways.</p>","PeriodicalId":8909,"journal":{"name":"Biogerontology","volume":"27 4","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148683252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-08-05DOI: 10.1007/s10522-026-10486-1
Elena Yushkova
In recent decades, there has been active research into how ionizing radiation at low doses, an inevitable factor in human activity, affects aging processes and which molecular genetic mechanisms underlie this influence. This study investigates the effects of mutations in PIWI subfamily genes (piwi and aub), which regulate transposable elements, on the lifespan of Drosophila melanogaster under conditions of genome instability induced by hobo transposons and chronic low-intensity irradiation (20 cGy). It is shown that dysfunction of piwi and aub modulates the activity of hobo transposons, increasing the frequency of their excisions/transpositions and recombinogenic activity, as confirmed by phenotypic and PCR analyses. The presence of hobo transposons in the genome elevates the spontaneous level of DNA fragmentation in ovarian cells, and chronic irradiation enhances this effect, leading to increased DNA damage in somatic and germline cells of most studied strains. Despite increased genetic instability and reduced fertility in some genotypes, the combined presence of mutations and hobo transposons paradoxically increases lifespan both under control conditions and after irradiation. Analysis of the interaction between genetic factors reveals a predominantly antagonistic, and in one case synergistic, effect on lifespan, depending on the type of mutation, the structure of the hobo transposons (full-size or defective copies), sex, and irradiation conditions. These results demonstrate the complex interplay between systems controlling transpositional activity and stress-induced processes that affect key viability parameters.
{"title":"Genetic interactions between PIWI subfamily genes and hobo transposons modulate Drosophila melanogaster lifespan under chronic low-intensity irradiation.","authors":"Elena Yushkova","doi":"10.1007/s10522-026-10486-1","DOIUrl":"https://doi.org/10.1007/s10522-026-10486-1","url":null,"abstract":"<p><p>In recent decades, there has been active research into how ionizing radiation at low doses, an inevitable factor in human activity, affects aging processes and which molecular genetic mechanisms underlie this influence. This study investigates the effects of mutations in PIWI subfamily genes (piwi and aub), which regulate transposable elements, on the lifespan of Drosophila melanogaster under conditions of genome instability induced by hobo transposons and chronic low-intensity irradiation (20 cGy). It is shown that dysfunction of piwi and aub modulates the activity of hobo transposons, increasing the frequency of their excisions/transpositions and recombinogenic activity, as confirmed by phenotypic and PCR analyses. The presence of hobo transposons in the genome elevates the spontaneous level of DNA fragmentation in ovarian cells, and chronic irradiation enhances this effect, leading to increased DNA damage in somatic and germline cells of most studied strains. Despite increased genetic instability and reduced fertility in some genotypes, the combined presence of mutations and hobo transposons paradoxically increases lifespan both under control conditions and after irradiation. Analysis of the interaction between genetic factors reveals a predominantly antagonistic, and in one case synergistic, effect on lifespan, depending on the type of mutation, the structure of the hobo transposons (full-size or defective copies), sex, and irradiation conditions. These results demonstrate the complex interplay between systems controlling transpositional activity and stress-induced processes that affect key viability parameters.</p>","PeriodicalId":8909,"journal":{"name":"Biogerontology","volume":"27 4","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148676950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Chronic morphine consumption induces oxidative stress and renal dysfunction, effects that may be exacerbated by aging-related declines in adaptive capacity. Regular endurance exercise enhances antioxidant defense and mitochondrial regulation; however, its ability to counteract morphine-induced renal alterations across different stages of aging remains insufficiently characterized.
Methods: Male wistar rats, categorized as young and aged based on chronological age and body weight, were allocated to control, morphine, exercise, and morphine plus exercise groups within each age category. Morphine was administered via drinking water for four weeks. Concurrently, animals in the exercise groups performed moderate-intensity continuous training on a treadmill. At study completion, serum and renal tissues were collected for assessment of oxidative stress markers (MDA, TAC, SOD), MPO, renal function indices (BUN and creatinine), and renal expression of sirtuin 1 (SIRT1) and Klotho, Mitochondrial compatibility markers (Citrate synthase activity and TFAM).
Results: Chronic morphine exposure was associated with increased oxidative stress markers and decreased antioxidant capacity in kidney tissue, and simultaneously increased serum urea and creatinine levels in young and old mice, indicating impaired renal functional status. Chronic morphine administration also decreased SIRT1 and Klotho levels in young and old animals. In contrast, 4 weeks of endurance training improved markers of mitochondrial adaptation, oxidative balance, and renal function, which were associated with increased expression of SIRT1 and Klotho in kidney tissue. These changes could indicate a potential link between exercise training and molecular pathways involved in the regulation of oxidative stress and renal homeostasis. However, these findings suggest an association, and causal or mechanistic interpretations will require further investigation in future studies.
Conclusion: These findings indicate that endurance training is associated with more favorable renal biomarker profiles in the context of chronic opioid exposure.
{"title":"Endurance training mitigates morphine-induced renal dysfunction in young and aged rats: involvement of oxidative stress, SIRT1, Klotho and TFAM.","authors":"Atena Alifarsangi, Saeedeh Ahmadinejad, Mohammad Amin Rajizadeh, Saeedeh Shojaeepour, Shahrzad Azizi, Alireza Keyhani, Fatemeh Darvishzadeh Mahani, Soheil Pardakhty","doi":"10.1007/s10522-026-10481-6","DOIUrl":"https://doi.org/10.1007/s10522-026-10481-6","url":null,"abstract":"<p><strong>Background: </strong>Chronic morphine consumption induces oxidative stress and renal dysfunction, effects that may be exacerbated by aging-related declines in adaptive capacity. Regular endurance exercise enhances antioxidant defense and mitochondrial regulation; however, its ability to counteract morphine-induced renal alterations across different stages of aging remains insufficiently characterized.</p><p><strong>Methods: </strong>Male wistar rats, categorized as young and aged based on chronological age and body weight, were allocated to control, morphine, exercise, and morphine plus exercise groups within each age category. Morphine was administered via drinking water for four weeks. Concurrently, animals in the exercise groups performed moderate-intensity continuous training on a treadmill. At study completion, serum and renal tissues were collected for assessment of oxidative stress markers (MDA, TAC, SOD), MPO, renal function indices (BUN and creatinine), and renal expression of sirtuin 1 (SIRT1) and Klotho, Mitochondrial compatibility markers (Citrate synthase activity and TFAM).</p><p><strong>Results: </strong>Chronic morphine exposure was associated with increased oxidative stress markers and decreased antioxidant capacity in kidney tissue, and simultaneously increased serum urea and creatinine levels in young and old mice, indicating impaired renal functional status. Chronic morphine administration also decreased SIRT1 and Klotho levels in young and old animals. In contrast, 4 weeks of endurance training improved markers of mitochondrial adaptation, oxidative balance, and renal function, which were associated with increased expression of SIRT1 and Klotho in kidney tissue. These changes could indicate a potential link between exercise training and molecular pathways involved in the regulation of oxidative stress and renal homeostasis. However, these findings suggest an association, and causal or mechanistic interpretations will require further investigation in future studies.</p><p><strong>Conclusion: </strong>These findings indicate that endurance training is associated with more favorable renal biomarker profiles in the context of chronic opioid exposure.</p>","PeriodicalId":8909,"journal":{"name":"Biogerontology","volume":"27 4","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148676974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aging-related neurological disorders, including stroke, Alzheimer's disease (AD), Parkinson's disease (PD), epilepsy, and various neuroinflammatory conditions, affect over three billion individuals worldwide and constitute leading causes of morbidity, disability, and socioeconomic burdens. Aging contributes not only to the increased incidence of these disorders but also to their progression through interconnected mechanisms, including endothelial dysfunction, oxidative stress, chronic inflammation, mitochondrial dysfunction, cellular senescence, metabolic imbalance, and gut microbiota dysbiosis. These processes collectively impair neuronal survival, synaptic plasticity, and cognitive and motor functions. Traditional Chinese medicine (TCM), with its characteristic multi-component and multi-target therapeutic strategies, has emerged as a promising approach to counteract age-associated neurological decline. Accumulating preclinical studies suggest that TCM interventions may exert neuroprotective, anti-inflammatory, and antioxidant effects, modulate autophagy, restore metabolic homeostasis, and potentially delay cellular senescence. However, high-quality clinical evidence on safety and efficacy remains limited. This review summarizes current insights into the molecular interplay between aging and neurological disorders and highlights the therapeutic potential of TCM in targeting hallmarks of aging, providing perspectives for integrative prevention and treatment strategies for neurodegenerative and neurovascular diseases.
{"title":"Research progress of traditional Chinese medicine interventions for aging-related nervous system diseases.","authors":"Xingyuan Du, Ziheng Shen, Yuanhao Xu, Weichu Song, Yanan Guo, Junping Kou, Shuaishuai Gong, Qianqian Ren","doi":"10.1007/s10522-026-10484-3","DOIUrl":"https://doi.org/10.1007/s10522-026-10484-3","url":null,"abstract":"<p><p>Aging-related neurological disorders, including stroke, Alzheimer's disease (AD), Parkinson's disease (PD), epilepsy, and various neuroinflammatory conditions, affect over three billion individuals worldwide and constitute leading causes of morbidity, disability, and socioeconomic burdens. Aging contributes not only to the increased incidence of these disorders but also to their progression through interconnected mechanisms, including endothelial dysfunction, oxidative stress, chronic inflammation, mitochondrial dysfunction, cellular senescence, metabolic imbalance, and gut microbiota dysbiosis. These processes collectively impair neuronal survival, synaptic plasticity, and cognitive and motor functions. Traditional Chinese medicine (TCM), with its characteristic multi-component and multi-target therapeutic strategies, has emerged as a promising approach to counteract age-associated neurological decline. Accumulating preclinical studies suggest that TCM interventions may exert neuroprotective, anti-inflammatory, and antioxidant effects, modulate autophagy, restore metabolic homeostasis, and potentially delay cellular senescence. However, high-quality clinical evidence on safety and efficacy remains limited. This review summarizes current insights into the molecular interplay between aging and neurological disorders and highlights the therapeutic potential of TCM in targeting hallmarks of aging, providing perspectives for integrative prevention and treatment strategies for neurodegenerative and neurovascular diseases.</p>","PeriodicalId":8909,"journal":{"name":"Biogerontology","volume":"27 4","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148652872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-07-28DOI: 10.1007/s10522-026-10471-8
Ihor Kendiukhov
<p><p>Single-cell foundation models such as scGPT and Geneformer are large neural networks trained on human single-cell RNA-seq data. They were never shown chronological age during training. Do their internal representations nevertheless encode aging biology in a way that can be interpreted, and how should we test whether an apparent aging signal is real biology rather than an artifact of which donors and cell types happened to be sampled?. We applied a nine-step evaluation pipeline to two foundation models (frozen, no fine-tuning) and five PBMC datasets containing 4 to 5 million cells from <math><mo>∼</mo></math> 2,000 donors with chronological age. Each step is one specific test: can we read age out of the model's representation; does the representation place age along a clean axis; do sparse-feature decompositions surface aging-related programs; do the two models agree at the pathway level; do targeted perturbations of those features change predicted age in the expected direction; and finally, does the signal survive when we resample cells so that young and old donors have matched cell-type composition (removing the most obvious confound). (1) The foundation models encode age but do not predict it better than a 50-component PCA of gene expression: in all five cohorts the PCA baseline matches or exceeds the best foundation-model probe. What they add is a complementary interpretability mode-sparse-feature decomposition and activation-level intervention-rather than predictive power; a PCA of gene expression is itself interpretable through its loadings, so the contribution here is the evaluation framework that adjudicates such signals, not a claim that foundation models predict age better. Randomly reinitialising Geneformer's weights destroys most of its age signal ( <math><mrow><mo>-</mo> <mn>0.107</mn></mrow> </math> balanced-accuracy points), while doing the same to scGPT's layer 9 changes essentially nothing-so the two models encode age asymmetrically. (2) Sparse autoencoders surface 132 robust aging-related features across the two models, of which 193 cross-model pairs match each other at pathway level, concentrated in inflammation. The shared inflammation signal resolves into specific submodules: TNF / NF- <math><mi>κ</mi></math> B classical and type-II IFN- <math><mi>γ</mi></math> (both models agree), complement (scGPT-specific). (3) The strongest aging signal is Geneformer's NF- <math><mi>κ</mi></math> B program in the AIDA phase 1 v2 cohort. Pushing those features in the "older" direction increases predicted age by 0.15 expected-age units; pushing them the opposite way decreases it; pushing along random unrelated directions does neither-a three-way directional check we call the "strict gate". When cells are resampled so that the age groups have matched cell-type composition (the strictest control), the directional effect shrinks <math><mo>∼</mo></math> 3 <math><mo>×</mo></math> but 7 of 8 resampling seeds still pass the strict gate. One i
{"title":"Inflammation-linked aging signals in frozen single-cell foundation models: donor-aware detection and robustness testing.","authors":"Ihor Kendiukhov","doi":"10.1007/s10522-026-10471-8","DOIUrl":"10.1007/s10522-026-10471-8","url":null,"abstract":"<p><p>Single-cell foundation models such as scGPT and Geneformer are large neural networks trained on human single-cell RNA-seq data. They were never shown chronological age during training. Do their internal representations nevertheless encode aging biology in a way that can be interpreted, and how should we test whether an apparent aging signal is real biology rather than an artifact of which donors and cell types happened to be sampled?. We applied a nine-step evaluation pipeline to two foundation models (frozen, no fine-tuning) and five PBMC datasets containing 4 to 5 million cells from <math><mo>∼</mo></math> 2,000 donors with chronological age. Each step is one specific test: can we read age out of the model's representation; does the representation place age along a clean axis; do sparse-feature decompositions surface aging-related programs; do the two models agree at the pathway level; do targeted perturbations of those features change predicted age in the expected direction; and finally, does the signal survive when we resample cells so that young and old donors have matched cell-type composition (removing the most obvious confound). (1) The foundation models encode age but do not predict it better than a 50-component PCA of gene expression: in all five cohorts the PCA baseline matches or exceeds the best foundation-model probe. What they add is a complementary interpretability mode-sparse-feature decomposition and activation-level intervention-rather than predictive power; a PCA of gene expression is itself interpretable through its loadings, so the contribution here is the evaluation framework that adjudicates such signals, not a claim that foundation models predict age better. Randomly reinitialising Geneformer's weights destroys most of its age signal ( <math><mrow><mo>-</mo> <mn>0.107</mn></mrow> </math> balanced-accuracy points), while doing the same to scGPT's layer 9 changes essentially nothing-so the two models encode age asymmetrically. (2) Sparse autoencoders surface 132 robust aging-related features across the two models, of which 193 cross-model pairs match each other at pathway level, concentrated in inflammation. The shared inflammation signal resolves into specific submodules: TNF / NF- <math><mi>κ</mi></math> B classical and type-II IFN- <math><mi>γ</mi></math> (both models agree), complement (scGPT-specific). (3) The strongest aging signal is Geneformer's NF- <math><mi>κ</mi></math> B program in the AIDA phase 1 v2 cohort. Pushing those features in the \"older\" direction increases predicted age by 0.15 expected-age units; pushing them the opposite way decreases it; pushing along random unrelated directions does neither-a three-way directional check we call the \"strict gate\". When cells are resampled so that the age groups have matched cell-type composition (the strictest control), the directional effect shrinks <math><mo>∼</mo></math> 3 <math><mo>×</mo></math> but 7 of 8 resampling seeds still pass the strict gate. One i","PeriodicalId":8909,"journal":{"name":"Biogerontology","volume":"27 4","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13407579/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148598544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Endothelial senescence is a critical contributor to vascular aging and age-related vasculopathies. Our previous work identified AGGF1 as a regulator of cell cycle progression and anti-inflammatory signaling. However, whether AGGF1 modulates endothelial senescence remains unclear. Here, we demonstrate that AGGF1 is downregulated in both replicative and DOX-induced senescent HUVECs. AGGF1 knockdown accelerated cellular senescence as evidenced by senescence markers, including increased SA-β-gal activity, enhanced formation of γH2AX foci, elevated IL-6 levels, and impaired proliferation, whereas AGGF1 overexpression prevented DOX- and MMC-induced senescence using adenovirus and lentivirus-mediated gene manipulation. To investigate the underlying mechanisms, we performed RNA sequencing, small-molecule drug intervention, transmission electron microscopy (TEM), and other imaging techniques in subsequent experiments. Transcriptomic and functional analyses revealed that AGGF1 transcriptionally upregulates TGFB3, which is associated with TAK1 activation and AMPK phosphorylation, ultimately inhibiting excessive mitochondrial fragmentation and suppressing cellular senescence. This signaling module reduced DRP1 expression and attenuated its activating phosphorylation at Ser616. TEM results further confirmed that AGGF1 overexpression significantly reduced mitochondrial fragmentation in cells. Additionally, this proposed association was supported by pharmacological inhibition (Takinib, Compound C) and TGFB3 knockdown, which abrogated AGGF1-mediated protection. Collectively, we identified that AGGF1 is critical for regulating a proposed TGFB3-TAK1-AMPK regulatory module, which delays endothelial senescence partially through maintenance of mitochondrial morphology. Our study provides evidence that AGGF1 plays an important role in metabolic control and cellular senescence.
{"title":"AGGF1 delays endothelial cellular senescence through the TGFB3-TAK1-AMPK signaling axis.","authors":"Xiaojuan Zhong, Weixin Lv, Xueer Li, Limei Wang, Minhong Zhang, Kang Liu, Jiayi Dong, Qiang Yuan, Shilin Zhang, Andong Wu, Xueting Gong, Jiankun Liu, Bingbing Zhou, Shihui Ye, Qiquan Wang, Yang Xiang, Xiao-Li Tian","doi":"10.1007/s10522-026-10474-5","DOIUrl":"10.1007/s10522-026-10474-5","url":null,"abstract":"<p><p>Endothelial senescence is a critical contributor to vascular aging and age-related vasculopathies. Our previous work identified AGGF1 as a regulator of cell cycle progression and anti-inflammatory signaling. However, whether AGGF1 modulates endothelial senescence remains unclear. Here, we demonstrate that AGGF1 is downregulated in both replicative and DOX-induced senescent HUVECs. AGGF1 knockdown accelerated cellular senescence as evidenced by senescence markers, including increased SA-β-gal activity, enhanced formation of γH2AX foci, elevated IL-6 levels, and impaired proliferation, whereas AGGF1 overexpression prevented DOX- and MMC-induced senescence using adenovirus and lentivirus-mediated gene manipulation. To investigate the underlying mechanisms, we performed RNA sequencing, small-molecule drug intervention, transmission electron microscopy (TEM), and other imaging techniques in subsequent experiments. Transcriptomic and functional analyses revealed that AGGF1 transcriptionally upregulates TGFB3, which is associated with TAK1 activation and AMPK phosphorylation, ultimately inhibiting excessive mitochondrial fragmentation and suppressing cellular senescence. This signaling module reduced DRP1 expression and attenuated its activating phosphorylation at Ser616. TEM results further confirmed that AGGF1 overexpression significantly reduced mitochondrial fragmentation in cells. Additionally, this proposed association was supported by pharmacological inhibition (Takinib, Compound C) and TGFB3 knockdown, which abrogated AGGF1-mediated protection. Collectively, we identified that AGGF1 is critical for regulating a proposed TGFB3-TAK1-AMPK regulatory module, which delays endothelial senescence partially through maintenance of mitochondrial morphology. Our study provides evidence that AGGF1 plays an important role in metabolic control and cellular senescence.</p>","PeriodicalId":8909,"journal":{"name":"Biogerontology","volume":"27 4","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13415593/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148598425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-07-25DOI: 10.1007/s10522-026-10479-0
Sheena Yi-Hsin Cheng, Yi-Chiung Hsu
Age is a major risk factor for cardiovascular disease, yet the molecular mechanisms underlying human cardiac aging are not fully understood. Using bulk RNA sequencing data from the Genotype-Tissue Expression (GTEx) project, we identified cardiac age-associated genes by intersecting transcripts significantly correlated with age in both the atrial appendage and left ventricle, while excluding those similarly altered in skeletal muscle. Among these, 131 genes were positively correlated with age, and 262 were negatively correlated. Functional enrichment and gene set enrichment analyses revealed several recurring biological themes. Pathways positively enriched with age included the P53 pathway, replicative senescence, extracellular matrix organization, transient receptor potential channel activity, and cardiac epithelial-mesenchymal transition. Conversely, negatively enriched pathways involved fatty acid oxidation, oxidative phosphorylation, mitochondrial biogenesis, membrane repolarization, cardiac conduction, and NOS1 signaling. Immune deconvolution indicated an age-dependent increase in neutrophil fractions and a decrease in monocyte abundance. Finally, an ordinal elastic net regression model, trained on these cardiac age-associated genes, demonstrated acceptable internal performance, achieving a quadratic weighted kappa of 0.797 and an ordinal concordance index of 0.901. External validation on two independent microarray cohorts showed modest predictive capability, with R2 values of 0.20 and 0.38. These findings provide a transcriptomic landscape of cardiac aging based on human tissue, with potential implications for biomarker development and therapeutic strategies.
{"title":"Transcriptomic landscape of human cardiac aging: identification of cardioselective age-associated genes and predictive modeling.","authors":"Sheena Yi-Hsin Cheng, Yi-Chiung Hsu","doi":"10.1007/s10522-026-10479-0","DOIUrl":"https://doi.org/10.1007/s10522-026-10479-0","url":null,"abstract":"<p><p>Age is a major risk factor for cardiovascular disease, yet the molecular mechanisms underlying human cardiac aging are not fully understood. Using bulk RNA sequencing data from the Genotype-Tissue Expression (GTEx) project, we identified cardiac age-associated genes by intersecting transcripts significantly correlated with age in both the atrial appendage and left ventricle, while excluding those similarly altered in skeletal muscle. Among these, 131 genes were positively correlated with age, and 262 were negatively correlated. Functional enrichment and gene set enrichment analyses revealed several recurring biological themes. Pathways positively enriched with age included the P53 pathway, replicative senescence, extracellular matrix organization, transient receptor potential channel activity, and cardiac epithelial-mesenchymal transition. Conversely, negatively enriched pathways involved fatty acid oxidation, oxidative phosphorylation, mitochondrial biogenesis, membrane repolarization, cardiac conduction, and NOS1 signaling. Immune deconvolution indicated an age-dependent increase in neutrophil fractions and a decrease in monocyte abundance. Finally, an ordinal elastic net regression model, trained on these cardiac age-associated genes, demonstrated acceptable internal performance, achieving a quadratic weighted kappa of 0.797 and an ordinal concordance index of 0.901. External validation on two independent microarray cohorts showed modest predictive capability, with R<sup>2</sup> values of 0.20 and 0.38. These findings provide a transcriptomic landscape of cardiac aging based on human tissue, with potential implications for biomarker development and therapeutic strategies.</p>","PeriodicalId":8909,"journal":{"name":"Biogerontology","volume":"27 4","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148589504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-07-25DOI: 10.1007/s10522-026-10478-1
Roberta Di Pietro, Rosa Mancinelli, Gianna Impicciatore, Gianmarco Stati, Stefania Fulle, Silvia Sancilio
Satellite cells (SCs) are essential for skeletal muscle regeneration, but their function declines with aging, often associated with increased pro-apoptotic signaling. This study investigated the impact of in vitro serum starvation-as a model of acute microenvironmental and nutrient stress-on the apoptosis and differentiation potential of human SCs from young and aged donors. SCs were isolated from the Vastus Lateralis of young and aged subjects and cultured in serum-free medium for up to 72 h. We assessed apoptosis through Annexin V/PI staining, TUNEL assays, and caspase activity measurements, while transcriptional profiles were analyzed via RT-PCR. Aged SCs displayed a significantly higher susceptibility to stress-induced apoptosis compared to young controls, marked by the early upregulation of CASP9 and FOXO1. While typical nucleosomal DNA fragmentation was absent, we observed the activation of caspase-3 after 72 h of starvation. In aged cells, activated caspase-3 co-localized with myogenin and extranuclear DNA at sites of nuclear remodeling. Notably, treatment with a pan-caspase inhibitor (z-VAD-fmk) prevented the formation of micronuclei and myotubes, further highlighting a non-apoptotic role for these enzymes. Aged SCs also showed a distinct cell cycle profile characterized by an enlarged G0/G1 phase and altered expression of CDK and CCNB1 genes. Our findings suggest that in human aged SCs, caspase enzymes serve a dual role: mediating a heightened stress response and facilitating the nuclear remodeling necessary for myogenic differentiation. These results clarify how intrinsic aging shapes the response of muscle stem cells under severe environmental and metabolic resource deprivation.
{"title":"Non-apoptotic role of caspase enzymes in satellite cells from human skeletal muscle.","authors":"Roberta Di Pietro, Rosa Mancinelli, Gianna Impicciatore, Gianmarco Stati, Stefania Fulle, Silvia Sancilio","doi":"10.1007/s10522-026-10478-1","DOIUrl":"10.1007/s10522-026-10478-1","url":null,"abstract":"<p><p>Satellite cells (SCs) are essential for skeletal muscle regeneration, but their function declines with aging, often associated with increased pro-apoptotic signaling. This study investigated the impact of in vitro serum starvation-as a model of acute microenvironmental and nutrient stress-on the apoptosis and differentiation potential of human SCs from young and aged donors. SCs were isolated from the Vastus Lateralis of young and aged subjects and cultured in serum-free medium for up to 72 h. We assessed apoptosis through Annexin V/PI staining, TUNEL assays, and caspase activity measurements, while transcriptional profiles were analyzed via RT-PCR. Aged SCs displayed a significantly higher susceptibility to stress-induced apoptosis compared to young controls, marked by the early upregulation of CASP9 and FOXO1. While typical nucleosomal DNA fragmentation was absent, we observed the activation of caspase-3 after 72 h of starvation. In aged cells, activated caspase-3 co-localized with myogenin and extranuclear DNA at sites of nuclear remodeling. Notably, treatment with a pan-caspase inhibitor (z-VAD-fmk) prevented the formation of micronuclei and myotubes, further highlighting a non-apoptotic role for these enzymes. Aged SCs also showed a distinct cell cycle profile characterized by an enlarged G0/G1 phase and altered expression of CDK and CCNB1 genes. Our findings suggest that in human aged SCs, caspase enzymes serve a dual role: mediating a heightened stress response and facilitating the nuclear remodeling necessary for myogenic differentiation. These results clarify how intrinsic aging shapes the response of muscle stem cells under severe environmental and metabolic resource deprivation.</p>","PeriodicalId":8909,"journal":{"name":"Biogerontology","volume":"27 4","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13401550/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148590416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-07-23DOI: 10.1007/s10522-026-10477-2
Piotr Paweł Chmielewski
Cellular senescence is a context-dependent cellular state characterised by persistent cell-cycle arrest, epigenetic remodelling, metabolic reprogramming and acquisition of a senescence-associated secretory phenotype. Transient senescence contributes to embryogenesis, tissue repair and tumour suppression, whereas persistent senescent cell populations accumulate with advancing age across multiple tissues, in part owing to declining immune-mediated clearance and intrinsic resistance to apoptosis, thereby promoting chronic systemic inflammation, tissue fibrosis, stem-cell dysfunction and propagation of secondary senescence. Experimental genetic and pharmacological evidence supports a contributory and in several contexts causal role for senescent cells in cardiovascular, metabolic, musculoskeletal, fibrotic and neurodegenerative disorders. These findings have accelerated the development of senotherapeutic strategies, including senolytics, senomorphics and immune-mediated clearance approaches, with early clinical studies showing preliminary evidence of functional benefit in idiopathic pulmonary fibrosis and diabetic kidney disease. However, clinical translation remains constrained by senescence heterogeneity, limited biomarker specificity and unresolved long-term safety concerns. Improved molecular, spatial and functional resolution of senescent states will be essential for developing biomarker-guided and tissue-specific interventions that preserve the beneficial functions of transient senescence while limiting its chronic deleterious effects.
{"title":"Cellular senescence and inflammageing: from mechanisms to senotherapeutic interventions.","authors":"Piotr Paweł Chmielewski","doi":"10.1007/s10522-026-10477-2","DOIUrl":"10.1007/s10522-026-10477-2","url":null,"abstract":"<p><p>Cellular senescence is a context-dependent cellular state characterised by persistent cell-cycle arrest, epigenetic remodelling, metabolic reprogramming and acquisition of a senescence-associated secretory phenotype. Transient senescence contributes to embryogenesis, tissue repair and tumour suppression, whereas persistent senescent cell populations accumulate with advancing age across multiple tissues, in part owing to declining immune-mediated clearance and intrinsic resistance to apoptosis, thereby promoting chronic systemic inflammation, tissue fibrosis, stem-cell dysfunction and propagation of secondary senescence. Experimental genetic and pharmacological evidence supports a contributory and in several contexts causal role for senescent cells in cardiovascular, metabolic, musculoskeletal, fibrotic and neurodegenerative disorders. These findings have accelerated the development of senotherapeutic strategies, including senolytics, senomorphics and immune-mediated clearance approaches, with early clinical studies showing preliminary evidence of functional benefit in idiopathic pulmonary fibrosis and diabetic kidney disease. However, clinical translation remains constrained by senescence heterogeneity, limited biomarker specificity and unresolved long-term safety concerns. Improved molecular, spatial and functional resolution of senescent states will be essential for developing biomarker-guided and tissue-specific interventions that preserve the beneficial functions of transient senescence while limiting its chronic deleterious effects.</p>","PeriodicalId":8909,"journal":{"name":"Biogerontology","volume":"27 4","pages":""},"PeriodicalIF":5.3,"publicationDate":"2026-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13396041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148560874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}